Drug Discovery Outsourcing: World Market 2011-2021

28 Sep 2011 • by Natalie Aster

In 2010, the Canadian drug discovery outsourcing market was worth an estimated $1.08bn. During the period 2010-2015, this market will grow with a CAGR of 16.85%. By 2015, Visiongain estimates that this market will be worth $2.35bn.

The report “Drug Discovery Outsourcing: World Market 2011-2021” by Visiongain shows potential revenues for outsourced drug discovery at total world, submarket and national levels. The study gives data on prospects for contract research providers and sponsors of early-stage pharma R&D.

Report Details:

Drug Discovery Outsourcing: World Market 2011-2021

Published: July 2011
Pages: 122
Price: US$ 2,461.00

Report Sample Abstract

The Canadian Drug Discovery Outsourcing Market, 2010-2021

One of the strengths of this market is the relative maturity of the Canadian pharmaceutical industry. Given the close proximity of Canada and the US, many US-based drug manufacturers outsource work to Canada.

Figure 6.7 The Canadian Drug Discovery Outsourcing Market ($bn), 2010-2015

Source: Visiongain 2011

By 2016 this market will be worth an estimated $2.71bn, growing to $5.23bn by 2021. Visiongain forecasts a CAGR of 14.09% for this market (2016-2021).

Figure 6.8 The Canadian Drug Discovery Outsourcing Market ($bn), 2016-2021